Literature DB >> 10814801

Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis.

O H Kantarci1, E J Atkinson, D D Hebrink, C T McMurray, B G Weinshenker.   

Abstract

We studied the putative association of a C-->T polymorphism in exon-5 of IL-1beta and an 85 bp tandem repeat in intron-4 of IL-1 receptor antagonist (IL-1ra) genes with susceptibility to or outcome of MS. DNA from 122 cases from a population-based cohort in Olmsted County, MN who were previously categorized for disease severity and temporal course and 244 ethnically-matched controls were analyzed. There was no association between either polymorphism and disease susceptibility. Allele-2 of IL-1beta and allele-3 of the IL-1ra polymorphisms were associated with a favorable outcome (P=0.023 and P=0.030).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10814801     DOI: 10.1016/s0165-5728(00)00202-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

1.  Polymorphisms for interleukin-1 beta (IL-1 beta)-511 promoter, IL-1 beta exon 5, and IL-1 receptor antagonist: nonassociation with endometriosis.

Authors:  Y Y Hsieh; C C Chang; F J Tsai; J Y Wu; Y R Shi; H D Tsai; C H Tsai
Journal:  J Assist Reprod Genet       Date:  2001-09       Impact factor: 3.412

Review 2.  Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.

Authors:  Meysam Moghbeli
Journal:  Cell Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.046

3.  Association of interleukin-1 gene polymorphisms with multiple sclerosis: a meta-analysis.

Authors:  Jian Huang; Zi-Kang Xie; Rong-Bin Lu; Zheng-Fu Xie
Journal:  Inflamm Res       Date:  2012-10-04       Impact factor: 4.575

4.  Magnetisation transfer ratio analysis of normal appearing white matter in patients with familial and sporadic multiple sclerosis.

Authors:  M Siger-Zajdel; K Selmaj
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

5.  IL1RN intron 2 polymorphism caused by variable number tandem repeats is associated with 1-year outcome in patients with ischaemic stroke.

Authors:  G Gromadzka; I Sarzynska-Dlugosz; A Czlonkowska
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-15       Impact factor: 10.154

6.  The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18.

Authors:  Sushmita Jha; Siddharth Y Srivastava; W June Brickey; Heather Iocca; Arrel Toews; James P Morrison; Vivian S Chen; Denis Gris; Glenn K Matsushima; Jenny P-Y Ting
Journal:  J Neurosci       Date:  2010-11-24       Impact factor: 6.167

7.  Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients.

Authors:  Cathy J Jensen; Jim Stankovich; Anneke Van der Walt; Melanie Bahlo; Bruce V Taylor; Ingrid A F van der Mei; Simon J Foote; Trevor J Kilpatrick; Laura J Johnson; Ella Wilkins; Judith Field; Patrick Danoy; Matthew A Brown; Justin P Rubio; Helmut Butzkueven
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

8.  Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms in Greek multiple sclerosis (MS) patients with bout-onset MS.

Authors:  Konstantinos Aggelakis; Fani Zacharaki; Efthimios Dardiotis; Georgia Xiromerisiou; Vana Tsimourtou; Styliani Ralli; Maria Gkaraveli; Dimitris Bourpoulas; Paraskevi Rodopoulou; Alexandros Papadimitriou; Georgios Hadjigeorgiou
Journal:  Neurol Sci       Date:  2009-10-30       Impact factor: 3.307

9.  Association of interleukin 1 gene family polymorphisms with duodenal ulcer disease.

Authors:  M A García-González; A Lanas; P H M Savelkoul; S Santolaria; R Benito; J B A Crusius; A S Peña
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

Review 10.  The role of interferon-β in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes.

Authors:  Makoto Inoue; Mari L Shinohara
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.